FDA Clears Home Urine Collection Kit for STI Testing - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA Clears Home Urine Collection Kit for STI Testing

The clearance enables a validated mail-in workflow for self-collected urine specimens processed on Roche cobas systems.

  • By

  • Kathryn Wighton

  • June 11, 2026

  • 2 min

Share

  • 1

    The FDA has cleared the Colli-Pee Dx Urine Collection Kit for at-home STI testing using Roche assays.

  • 2

    The kit allows collection of first-void urine specimens for detecting Chlamydia, Gonorrhea, Trichomonas, and Mycoplasma.

  • 3

    It incorporates NucleoPrecision Technology to stabilize DNA and RNA in urine specimens at ambient temperatures.

  • 4

    Health care providers can prescribe the kit, enabling direct mail-in specimen collection for laboratory testing.

  • 5

    OraSure Technologies aims to enhance user-friendly testing options in decentralized settings with this innovation.

Original Source(s)

FDA Clears Home Urine Collection Kit for STI Testing

  • by Kathryn Wighton

  • June 11, 2026

Related Content

AI Tool Finds More Long COVID Cases Than Codes

Nearly 90% of patients who met algorithmic criteria for postacute sequelae of SARS-CoV-2 infection had at least 1 chronic or potentially chronic condition requiring ongoing clinical management.

Genomic insights into emerging South Korean uncommon Orientia tsutsugamushi strains and their value as new surveillance resources

CDC: Measles cases surpass 4,000 in 2026

CDC data show that 96% of cases are outbreak-associated, with adults accounting for 40% of cases, up from 29% in 2025.